- Home
- PRAX vs M Comparison
PRAX vs M Comparison
Compare PRAX & M Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- M
- Stock Information
- Founded
- PRAX 2015
- M 1830
- Country
- PRAX United States
- M United States
- Employees
- PRAX N/A
- M N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- M Department/Specialty Retail Stores
- Sector
- PRAX Health Care
- M Consumer Discretionary
- Exchange
- PRAX Nasdaq
- M Nasdaq
- Market Cap
- PRAX 4.0B
- M 4.8B
- IPO Year
- PRAX 2020
- M N/A
- Fundamental
- Price
- PRAX $178.75
- M $18.62
- Analyst Decision
- PRAX Strong Buy
- M Hold
- Analyst Count
- PRAX 13
- M 10
- Target Price
- PRAX $202.85
- M $15.72
- AVG Volume (30 Days)
- PRAX 1.4M
- M 7.9M
- Earning Date
- PRAX 11-07-2025
- M 11-25-2025
- Dividend Yield
- PRAX N/A
- M 3.91%
- EPS Growth
- PRAX N/A
- M 304.55
- EPS
- PRAX N/A
- M 1.77
- Revenue
- PRAX $7,765,000.00
- M $22,701,000,000.00
- Revenue This Year
- PRAX N/A
- M N/A
- Revenue Next Year
- PRAX $20.00
- M N/A
- P/E Ratio
- PRAX N/A
- M $10.56
- Revenue Growth
- PRAX 338.45
- M N/A
- 52 Week Low
- PRAX $26.70
- M $9.76
- 52 Week High
- PRAX $205.89
- M $19.08
- Technical
- Relative Strength Index (RSI)
- PRAX 80.27
- M 65.71
- Support Level
- PRAX $164.75
- M $17.61
- Resistance Level
- PRAX $192.96
- M $18.18
- Average True Range (ATR)
- PRAX 11.99
- M 0.57
- MACD
- PRAX 13.57
- M -0.01
- Stochastic Oscillator
- PRAX 82.53
- M 86.89
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About M Macy's Inc
Founded in 1858 and based in New York City, Macy's operates about 450 stores under the Macy's name, nearly 60 stores under the Bloomingdale's (full-price and outlet) and Bloomie's names, and more than 170 freestanding Bluemercury specialty beauty stores. Macy's also operates e-commerce sites and licenses Bloomingdale's stores in the United Arab Emirates and Kuwait. Women's apparel, accessories, shoes, cosmetics, and fragrances constitute about 62% of Macy's sales.